[Federal Register Volume 74, Number 235 (Wednesday, December 9, 2009)]
[Notices]
[Pages 65133-65134]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-29236]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the

[[Page 65134]]

provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Pharmaceutical Approaches for Development of 
Pharmacotherapies for Drug Addiction (8893).
    Date: December 16, 2009.
    Time: 9:30 a.m. to 12 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6101 Executive Boulevard, 
Rockville, MD 20852 (Telephone Conference Call).
    Contact Person: Lyle Furr, Contract Review Specialist, Office of 
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, 
Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401, (301) 435-1439, lf33c.nih.gov.

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, New Technologies: Integrating Data from 
Prescription, Monitoring Program(s) to Current Clinical Practice 
(2218).
    Date: December 16, 2009.
    Time: 1:30 p.m. to 3 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6101 Executive Boulevard, 
Rockville, MD 20852 (Telephone Conference Call).
    Contact Person: Lyle Furr, Contract Review Specialist, Office of 
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, 
Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401, (301) 435-1439, lf33c.nih.gov.

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, N43DA-10-7775: Tool Development for New or Improved 
Capture Reagents.
    Date: January 7, 2010.
    Time: 12 p.m. to 4 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6101 Executive Boulevard, 
Rockville, MD 20852 (Telephone Conference Call).
    Contact Person: Minna Liang, PhD, Scientific Review Officer, 
Training and Special Projects Review Branch, Office of Extramural 
Affairs, National Institute on Drug Abuse, NIH, 6101 Executive 
Blvd., Room 220, MSC 8401, Bethesda, MD 20852, 301-435-1432, 
[email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Web Based Cognitive/Neuropsychological Testing, for 
Substance Abuse (4412).
    Date: January 12, 2010.
    Time: 9:30 a.m. to 12 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6101 Executive Boulevard, 
Rockville, MD 20852 (Telephone Conference Call).
    Contact Person: Lyle Furr, Contract Review Specialist, Office of 
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, 
Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401, (301) 435-1439, lf33c.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)


    Dated: December 2, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-29236 Filed 12-8-09; 8:45 am]
BILLING CODE 4140-01-M